Oragenics Announces Closing of $12.5 Million Underwritten Public Offering
TAMPA, Fla.–(BUSINESS WIRE)–Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective…
Pharmaceuticals, Biotechnology and Life Sciences
TAMPA, Fla.–(BUSINESS WIRE)–Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective…
This live symposium will be held adjunct to the 2019 American College of Physicians Internal Medicine Meeting CRANBURY, N.J.–(BUSINESS WIRE)–lt;a…
DUBLIN–(BUSINESS WIRE)–The “2018 Biotechnology Research Review” report has been added to ResearchAndMarkets.com’s offering. Several significant developments have aided and accelerated…
Treatment with Gelesis hydrogel prevented unwanted substances from entering the circulation in mice with severe gut wall injury Data suggest…
Individuals with prediabetes and those with untreated type 2 diabetes had six times higher odds to achieve ≥10% weight loss…
DUBLIN–(BUSINESS WIRE)–The “Fibromyalgia – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Fibromyalgia – Pipeline Review,…
DUBLIN–(BUSINESS WIRE)–The “Diarrhea – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Diarrhea – Pipeline Review,…
DUBLIN–(BUSINESS WIRE)–The “Alopecia – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Alopecia – Pipeline Review,…
DUBLIN–(BUSINESS WIRE)–The “Anthrax – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Anthrax – Pipeline Review,…
DUBLIN–(BUSINESS WIRE)–The “Diabetic Gastroparesis – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Diabetic Gastroparesis –…